Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001785530-19-000001
Filing Date
2019-08-15
Accepted
2019-08-15 13:18:31
Documents
1
Effectiveness Date
2019-08-15
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 9765
  Complete submission text file 0001785530-19-000001.txt   10844
Mailing Address 1030 MASSACHUSETTS AVENUE SUITE 210 CAMBRIDGE MA 02138
Business Address 1030 MASSACHUSETTS AVENUE SUITE 210 CAMBRIDGE MA 02138 617-952-0555
Werewolf Therapeutics, Inc. (Filer) CIK: 0001785530 (see all company filings)

IRS No.: 823523180 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-346661 | Film No.: 191029529